98 related articles for article (PubMed ID: 2862629)
21. [Familial pheochromocytoma in Sipple's syndrome. A comparison between scintigraphy with 131I-meta-iodobenzylguanidine, computed tomography and echography].
Maurea S; Maurelli L; Lastoria S; Cuocolo A; Brunetti A; Pace L; Caracò C; Klain M; Lupoli G; Salvatore M
Radiol Med; 1992 Apr; 83(4):486-90. PubMed ID: 1351307
[No Abstract] [Full Text] [Related]
22. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.
Hilditch TE; Connell JM; Elliot AT; Murray T; Reed NS
J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086
[TBL] [Abstract][Full Text] [Related]
23. [Scintigraphy of medullary carcinoma of the thyroid by new radiopharmaceuticals].
Tada J; Konishi J; Torizuka K; Makimoto K; Miyauchi A
Rinsho Hoshasen; 1984 Sep; 29(9):1043-4. PubMed ID: 6096600
[No Abstract] [Full Text] [Related]
24. [The evaluation of 123I-MIBG scintigraphy in medullary thyroid carcinoma (MTC)].
Ahuja S; Koppenhagen K; Ernst H
Strahlenther Onkol; 1990 Nov; 166(11):718-21. PubMed ID: 2260009
[TBL] [Abstract][Full Text] [Related]
25. The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
Zagar I; Mitrović S; Adanja G; Maksimović L; Ivanovski P; Han R; Kovacić K
Med Pregl; 1993; 46 Suppl 1():74-5. PubMed ID: 8569615
[TBL] [Abstract][Full Text] [Related]
26. Localization of m-iodo(131I)benzylguanidine in neuroblastoma.
Hattner RS; Huberty JP; Engelstad BL; Gooding CA; Ablin AR
AJR Am J Roentgenol; 1984 Aug; 143(2):373-4. PubMed ID: 6611071
[No Abstract] [Full Text] [Related]
27. Results of [131I]metaiodobenzylguanidine therapy administered to two patients with medullary carcinoma of the thyroid.
Schvartz C; Delisle MJ
J Nucl Biol Med (1991); 1991; 35(4):332-3. PubMed ID: 1823850
[TBL] [Abstract][Full Text] [Related]
28. Neuroblastoma imaged with 123I meta-iodo-benzylguanidine and with 123I-labelled monoclonal antibody, UJ13A, against neural tissue.
Horne T; Granowska M; Dicks-Mireaux C; Hawkins LA; Britton KE; Mather S; Bomanji J; Kemshead JT; Kingston J; Malpas JS
Br J Radiol; 1985 May; 58(689):476-80. PubMed ID: 4063701
[No Abstract] [Full Text] [Related]
29. Sipple syndrome.
Vaughan KD
Can Assoc Radiol J; 1989 Feb; 40(1):63-4. PubMed ID: 2564308
[No Abstract] [Full Text] [Related]
30. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers.
Jansson S; Tisell LE; Fjälling M; Lindberg S; Jacobsson L; Zachrisson BF
Surgery; 1988 Jan; 103(1):11-8. PubMed ID: 2892276
[TBL] [Abstract][Full Text] [Related]
31. Methodology and dosimetry in adrenal medullary imaging with iodine-131 MIBG.
Lindberg S; Fjälling M; Jacobsson L; Jansson S; Tisell LE
J Nucl Med; 1988 Oct; 29(10):1638-43. PubMed ID: 2902204
[TBL] [Abstract][Full Text] [Related]
32. Session on: has [131I]metaiodobenzylguanidine a role in the treatment of medullary thyroid cancer and carcinoid tumors? Chairman's report.
Bestagno M
J Nucl Biol Med (1991); 1991; 35(4):355-6. PubMed ID: 1823857
[No Abstract] [Full Text] [Related]
33. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.
Nakajo M; Shapiro B; Copp J; Kalff V; Gross MD; Sisson JC; Beierwaltes WH
J Nucl Med; 1983 Aug; 24(8):672-82. PubMed ID: 6135764
[TBL] [Abstract][Full Text] [Related]
34. [Intraoperative localization of pheochromocytoma metastases using 131I-meta-benzylguanidine].
Fasshauer H; Freundlieb O; Dostal G; Littmann K; Tharandt L; Strötges MW
Nuklearmedizin; 1984 Aug; 23(4):203-5. PubMed ID: 6483632
[No Abstract] [Full Text] [Related]
35. Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
Clarke SE; Lazarus CR; Maisey MN
Henry Ford Hosp Med J; 1987; 35(2-3):124-6. PubMed ID: 2826368
[No Abstract] [Full Text] [Related]
36. [Diagnosis and therapy control of neuroblastoma using meta-iodo- benzylguanidine].
Kimmig B; Brandeis WE; Adolph J
Dtsch Med Wochenschr; 1985 Feb; 110(5):175-9. PubMed ID: 3967603
[TBL] [Abstract][Full Text] [Related]
37. [131I]metaiodobenzylguanidine therapy in medullary thyroid cancer: Guy's Hospital experience.
Clarke SE
J Nucl Biol Med (1991); 1991; 35(4):323-6. PubMed ID: 1823848
[TBL] [Abstract][Full Text] [Related]
38. [The diagnosis of thyroid carcinoma].
Sandrock D; Munz DL
Dtsch Med Wochenschr; 1991 Jan; 116(2):77-8. PubMed ID: 1985815
[No Abstract] [Full Text] [Related]
39. Pathological case of the month. Medullary thyroid carcinoma in multiple endocrine neoplasia type IIB.
Mack E; Gilbert-Barness E
Am J Dis Child; 1992 Aug; 146(8):953-4. PubMed ID: 1353300
[No Abstract] [Full Text] [Related]
40. 131I-MIBG scintigraphy in neural crest tumours.
Samuel AM; Murugesan S; Kurkure PA; Advani SH; Sonawane GA; Noronha OP
Indian J Cancer; 1994 Jun; 31(2):103-10. PubMed ID: 7927441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
